Johnson & Johnson

詳細情報 Johnson & Johnson 企業名

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

企業情報

企業コードJNJ

会社名Johnson & Johnson

上場日Sep 25, 1944

最高経営責任者「CEO」Mr. Joaquin Boix Duato

従業員数138100

証券種類Ordinary Share

決算期末Sep 25

本社所在地One Johnson & Johnson Plaza

都市NEW BRUNSWICK

証券取引所NYSE Consolidated

国United States of America

郵便番号08933

電話番号17325242455

ウェブサイトhttps://www.jnj.com/

企業コードJNJ

上場日Sep 25, 1944

最高経営責任者「CEO」Mr. Joaquin Boix Duato

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

276.91K

-32.09%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

84.95K

+4047.85%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Ms. Kristen Mulholland

Chief Human Resources Officer, Executive Vice President

14.12K

+20.79%

Ms. Elizabeth (Liz) Forminard

Executive Vice President, Chief Legal Officer

10.90K

+30.72%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

10.66K

-64.23%

Mrs. Anne M. Mulcahy

Independent Director

8.41K

+3.87%

Mr. Hubert Joly

Independent Director

5.00K

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

276.91K

-32.09%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

84.95K

+4047.85%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Ms. Kristen Mulholland

Chief Human Resources Officer, Executive Vice President

14.12K

+20.79%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Oncology-DARZALEX

3.24B

14.79%

Interventional Solutions

2.10B

9.61%

Immunology-STELARA

1.63B

7.42%

Surgery-General

1.32B

6.04%

Surgery-Advanced

1.07B

4.90%

Other

12.53B

57.24%

地域別USD

会社名

収益

比率

United States

12.30B

56.21%

Europe

5.11B

23.34%

Asia-Pacific, Africa

3.31B

15.12%

Western Hemisphere, excluding U.S.

1.17B

5.33%

事業別

地域別

事業別USD

会社名

収益

比率

Oncology-DARZALEX

3.24B

14.79%

Interventional Solutions

2.10B

9.61%

Immunology-STELARA

1.63B

7.42%

Surgery-General

1.32B

6.04%

Surgery-Advanced

1.07B

4.90%

Other

12.53B

57.24%

株主

更新時刻: Tue, May 13

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.80%

State Street Global Advisors (US)

5.56%

BlackRock Institutional Trust Company, N.A.

5.36%

Geode Capital Management, L.L.C.

2.52%

JP Morgan Asset Management

1.46%

Other

75.30%

株主統計

比率

The Vanguard Group, Inc.

9.80%

State Street Global Advisors (US)

5.56%

BlackRock Institutional Trust Company, N.A.

5.36%

Geode Capital Management, L.L.C.

2.52%

JP Morgan Asset Management

1.46%

Other

75.30%

種類

株主統計

比率

Investment Advisor

38.85%

Investment Advisor/Hedge Fund

23.72%

Research Firm

3.08%

Pension Fund

2.22%

Bank and Trust

2.18%

Insurance Company

1.64%

Sovereign Wealth Fund

1.36%

Hedge Fund

0.58%

Family Office

0.08%

Other

26.29%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

5920

1.78B

73.89%

-7.65M

2025Q1

6002

1.80B

74.62%

+4.60M

2024Q4

5953

1.78B

74.14%

+8.28M

2024Q3

5699

1.77B

73.47%

+2.69M

2024Q2

5691

1.75B

72.75%

+9.12M

2024Q1

5685

1.73B

71.58%

-6.08M

2023Q4

5686

1.72B

71.40%

-7.80M

2023Q3

5524

1.72B

71.21%

-159.24M

2023Q2

5528

1.87B

71.81%

+6.27M

2023Q1

5490

1.85B

71.21%

-28.44M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

232.98M

9.68%

+1.17M

+0.50%

Mar 31, 2025

State Street Global Advisors (US)

133.79M

5.56%

-666.37K

-0.50%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

129.14M

5.37%

-857.93K

-0.66%

Mar 31, 2025

Geode Capital Management, L.L.C.

59.38M

2.47%

+1.72M

+2.98%

Mar 31, 2025

JP Morgan Asset Management

35.25M

1.47%

+11.21M

+46.62%

Mar 31, 2025

State Farm Insurance Companies

34.37M

1.43%

--

Mar 31, 2025

Norges Bank Investment Management (NBIM)

30.36M

1.26%

+1.26M

+4.34%

Dec 31, 2024

Morgan Stanley Smith Barney LLC

24.07M

1%

+1.16M

+5.06%

Mar 31, 2025

Wellington Management Company, LLP

22.65M

0.94%

-1.71M

-7.02%

Mar 31, 2025

BlackRock Asset Management Ireland Limited

19.70M

0.82%

-178.45K

-0.90%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Wed, Aug 6

銘柄名

比率

iShares U.S. Pharmaceuticals ETF

23.85%

FT Vest DJIA Dogs 10 Target Income ETF

9.78%

VanEck Pharmaceutical ETF

8.38%

First Trust NASDAQ Pharmaceuticals ETF

8.12%

Health Care Select Sector SPDR Fund

7.51%

Proshares Ultra Health Care

7.51%

JPMorgan Healthcare Leaders ETF

7.42%

iShares U.S. Healthcare ETF

7.26%

iShares Core High Dividend ETF

6.49%

Fidelity MSCI Health Care Index ETF

6.48%

詳細を見る

iShares U.S. Pharmaceuticals ETF

比率23.85%

FT Vest DJIA Dogs 10 Target Income ETF

比率9.78%

VanEck Pharmaceutical ETF

比率8.38%

First Trust NASDAQ Pharmaceuticals ETF

比率8.12%

Health Care Select Sector SPDR Fund

比率7.51%

Proshares Ultra Health Care

比率7.51%

JPMorgan Healthcare Leaders ETF

比率7.42%

iShares U.S. Healthcare ETF

比率7.26%

iShares Core High Dividend ETF

比率6.49%

Fidelity MSCI Health Care Index ETF

比率6.48%

配当金

過去5年間の配当金総支払額は 56.79B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Jan 02, 2025

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Mar 04, 2025 going ex on Feb 18, 2025

Feb 18, 2025

Mar 04, 2025

Feb 18, 2025

Oct 15, 2024

JNJ.NB Final Cash Dividend of gross USD 1.24 paid on Dec 10, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 10, 2024

Nov 26, 2024

Jul 17, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Sep 10, 2024 going ex on Aug 27, 2024

Aug 27, 2024

Sep 10, 2024

Aug 27, 2024

Apr 16, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Jun 04, 2024 going ex on May 20, 2024

May 21, 2024

Jun 04, 2024

May 20, 2024

Jan 02, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Mar 05, 2024 going ex on Feb 16, 2024

Feb 20, 2024

Mar 05, 2024

Feb 16, 2024

Oct 19, 2023

JNJ.NB Final Cash Dividend of gross USD 1.19 paid on Dec 05, 2023 going ex on Nov 20, 2023

Nov 21, 2023

Dec 05, 2023

Nov 20, 2023

Jul 20, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Apr 18, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Jun 06, 2023 going ex on May 22, 2023

May 23, 2023

Jun 06, 2023

May 22, 2023

Jan 03, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 07, 2023 going ex on Feb 17, 2023

Feb 21, 2023

Mar 07, 2023

Feb 17, 2023

Oct 18, 2022

JNJ.NB Final Cash Dividend of gross USD 1.13 paid on Dec 06, 2022 going ex on Nov 21, 2022

Nov 22, 2022

Dec 06, 2022

Nov 21, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

172.775USD

Johnson & Johnson

172.775

概要

企業名

金融